Fampridine and quality of life in individuals with multiple sclerosis
Abstract
Fampridine improves walking in patients with multiple sclerosis (pwMS). However, little is known about its impact on the quality of life (QoL) of pwMS.
Journal Articles
SpringerPlus
Year : 2016
Eloi Magnin : Connect in order to contact the contributor
https://hal-univ-fcomte.archives-ouvertes.fr/hal-03630208
Submitted on : Monday, April 4, 2022-6:55:56 PM
Last modification on : Monday, April 4, 2022-6:55:57 PM
Dates and versions
Identifiers
- HAL Id : hal-03630208 , version 1
- DOI : 10.1186/s40064-016-2776-2
- PUBMED : 27462518
- PUBMEDCENTRAL : PMC4943908
Cite
Yoshimasa Sagawa, Eloi Magnin, Laura Paillot, Thierry Moulin, Pierre Decavel. Fampridine and quality of life in individuals with multiple sclerosis. SpringerPlus, 2016, 5 (1), pp.1070. ⟨10.1186/s40064-016-2776-2⟩. ⟨hal-03630208⟩
Collections
11
View
0
Download